A Reversal for Thermo Fisher Scientific Inc (NYSE:TMO) Is Near. The Stock Has Decrease in Shorts

October 13, 2018 - By Marguerite Chambers

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Investors sentiment increased to 1.08 in Q2 2018. Its up 0.22, from 0.86 in 2018Q1. It increased, as 43 investors sold Thermo Fisher Scientific Inc. shares while 378 reduced holdings. 100 funds opened positions while 356 raised stakes. 332.19 million shares or 0.06% more from 331.98 million shares in 2018Q1 were reported.
Glenview Capital Mgmt Limited Liability Co owns 2.55 million shares. Deltec Asset holds 25,615 shares or 1.07% of its portfolio. The Delaware-based Dupont Cap Mngmt Corp has invested 0.15% in Thermo Fisher Scientific Inc. (NYSE:TMO). Principal Grp Incorporated reported 688,813 shares. Cornerstone invested in 98,137 shares. 1,299 were accumulated by Bailard. Bnp Paribas Asset Management Holding has invested 0.1% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Waters Parkerson & Ltd Liability Company has 209,909 shares for 3.74% of their portfolio. Acadian Asset Mgmt Limited Com holds 0% or 1,022 shares in its portfolio. Heritage Investors Management Corporation reported 17,463 shares or 0.22% of all its holdings. The Michigan-based Telemus Cap Limited Liability Com has invested 0.57% in Thermo Fisher Scientific Inc. (NYSE:TMO). Ontario – Canada-based Royal Financial Bank Of Canada has invested 0.19% in Thermo Fisher Scientific Inc. (NYSE:TMO). Cibc Ww Markets Inc invested 0.02% in Thermo Fisher Scientific Inc. (NYSE:TMO). Carret Asset Mgmt Limited Liability has invested 0.45% in Thermo Fisher Scientific Inc. (NYSE:TMO). Franklin Resources Incorporated has invested 0.03% in Thermo Fisher Scientific Inc. (NYSE:TMO).

Since May 18, 2018, it had 0 buys, and 4 insider sales for $21.13 million activity. HARRIS C MARTIN had sold 206 shares worth $44,174. 50,000 shares valued at $10.89M were sold by CASPER MARC N on Wednesday, June 13.

The stock of Thermo Fisher Scientific Inc (NYSE:TMO) registered a decrease of 9.24% in short interest. TMO’s total short interest was 3.68M shares in October as published by FINRA. Its down 9.24% from 4.05M shares, reported previously. With 928,200 shares average volume, it will take short sellers 4 days to cover their TMO’s short positions.

The stock increased 2.35% or $5.32 during the last trading session, reaching $231.41. About 1.66M shares traded or 22.82% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.20% since October 13, 2017 and is uptrending. It has outperformed by 7.58% the S&P500.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $93.21 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 39.08 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 4 analysts covering Thermo Fisher Scientific (NYSE:TMO), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Thermo Fisher Scientific had 7 analyst reports since April 26, 2018 according to SRatingsIntel. Morgan Stanley maintained the stock with “Overweight” rating in Thursday, July 26 report. The firm has “Overweight” rating given on Thursday, April 26 by Morgan Stanley. The stock has “Overweight” rating by Morgan Stanley on Wednesday, October 10. Barclays Capital maintained it with “Overweight” rating and $275 target in Monday, September 24 report. The company was maintained on Friday, July 13 by Morgan Stanley. The rating was maintained by Citigroup with “Buy” on Wednesday, October 10. The firm earned “Neutral” rating on Monday, September 17 by Goldman Sachs.

More recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on September 17, 2018. Also Seekingalpha.com published the news titled: “Thermo Fisher in-licenses CRISPR technologies” on September 18, 2018. Bizjournals.com‘s news article titled: “Mass. firms lost $36B in value in Wednesday’s stock selloff” with publication date: October 11, 2018 was also an interesting one.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>